A novel characterized multi-drug-resistant Pseudocitrobacter sp. isolated from a patient colonized while admitted to a tertiary teaching hospital

  15 February 2024

A novel bacterial species was isolated from a patient’s rectal swab, revealing 99.7% 16s rRNA identity to Pseudocitrobacter corydidari, an Asian cockroach-associated species. The isolate had the highest average nucleotide identity (ANI) at 0.9562, suggesting resistance to carbapenems, β-lactams, sulfonamides, fluoroquinolones, macrolides, aminoglycosides, and cephalosporins. The patient was colonized, not infected, and did not require antimicrobial treatment. Genome data for this new species have been submitted to GENBANK using the proposed nomenclature Pseudocitrobacter limerickensis.

Author(s): S.A. Kelly et al
Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed